TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

COVID-19: Textile factories face hurdles as they switch to producing medical gear

  • News Desk

    The Jakarta Post

Jakarta   /   Mon, March 30, 2020   /   07:50 am
COVID-19: Textile factories face hurdles as they switch to producing medical gear Health workers wearing protective gear take part in an exercise in handling a suspected COVID-19 patient at Sanglah Hopital in Denpasar, Bali, on Feb. 12. Indonesian textile factories are making changes to their production line by producing protective gear for medical personnel and a local start-up is producing test kits to support the nation’s battle against the COVID-19 pandemic. (JP/Zul Trio Anggono)

Indonesian textile factories are making changes to their production line by producing protective gear for medical personnel and a local start-up is producing test kits to support the nation’s battle against the COVID-19 pandemic. However, producing medical-grade supplies comes with major challenges.

Textile companies were racing to mass-produce masks and protective coveralls for medical workers, said PT Pan Brothers deputy CEO Anne Patricia Sutanto. The company agreed to produce 20 million washable masks and 100,000 jumpsuits by April, as ordered by the government and retailers as demand for personal protective equipment (PPE) skyrockets.

“The workers were initially flabbergasted by our decision. They asked me, ‘Bu, we are a garment exporting company, so how can we produce masks and coveralls?’ but I told them this is a humanitarian emergency and we did it,” she told The Jakarta Post on Thursday. Pan Brothers ordered nine of its factories to produce the equipment.

There is a global shortage of PPE, test kits and ventilators, all of which are crucial in slowing the spread of COVID-19. The Indonesian Medical Association (IDI) announced on March 23 that five doctors had died of the illness, in addition to a nurse who died of COVID-19 on March 12.

Read also: COVID-19: West Java medical personnel forced to use raincoats in lieu of hazmat suits

As a result of the quick changes in its factories’ production line, the PPE made by Pan Brothers is not officially medical grade as the company does not have a license to test for biocompatibility.

“There is not enough time for us to obtain medical-grade status as we are in an emergency,” Anne said, giving assurances that their masks and coveralls had the same specifications as medical-grade products.

Indonesia was identifying companies that had the capacity to produce PPE, test kits and ventilators to help the nation’s health workers, who had been treating COVID-19 cases since mid-February with inadequate protection, Finance Minister Sri Mulyani Indrawati said on March 26.

“In Indonesia we are taking steps to support companies that produce healthcare equipment. We will list them and see to their needs in increasing their production capacity,” Sri Mulyani told a teleconferenced media briefing after a virtual extraordinary G20 Leaders’ Summit.

Textile company PT Sri Rejeki Isman (Sritex) had been producing coveralls for medical workers since late January and began to deliver the products in the first week of February, the company’s spokesperson Joy Citra Dewi said.

“We use a specified waterproof and anti-microbial material that we developed for the PPE,” Joy told the Post in a written statement without disclosing the number of coveralls produced by the company.

Read also: Indonesian fashion designers help sew, donate protective gear for medical workers

Both Sritex and Pan Brothers are facing shortages for medical-grade raw materials, as local producers have been overwhelmed by demands. A limited number of companies can produce medical-grade materials as they require strict standards and certification, Joy said.

“The challenges that are being faced by other companies are the scarcity of materials to produce safe PPE. There is PPE currently circulating in the market that lacks the proper specifications, which could endanger medical personnel,” Joy said.

While basic PPE can be quickly produced by textile companies, local industries are still unable to produce more complex medical equipment such as ventilators and hospital beds.

A lack of technological capability in producing complex medical equipment had become a major hurdle for factories looking to shift their production line, Indonesian Chamber of Commerce (Kadin) deputy chairwoman Shinta Kamdani told the Post in a separate interview.

A mother comforts her daughter, who is undergoing a rapid test for COVID-19 at the Abadijaya community health center in Depok, West Java, on Friday. COVID-19 tests are being held in a number of community health centers in Depok.A mother comforts her daughter, who is undergoing a rapid test for COVID-19 at the Abadijaya community health center in Depok, West Java, on Friday. COVID-19 tests are being held in a number of community health centers in Depok. (JP/Riand Alfiandy)

Shinta said factories across Indonesia faced a decline in production capacity by an average of 30 percent due to disruptions to their supply chains as a result of the coronavirus.

“There are not many industries that are ready to produce medical equipment, especially in this kind of situation. Maybe big corporations have better technology that could be used to produce ventilators or hospital beds, but it's unattainable for mid-sized companies,” she said.

Carmakers around the world are also shifting gear, producing hospital ventilators and respirators using 3D printing. Ford, General Motors, Ferrari and Nissan, alongside General Electrics and 3M Co., are among the companies that have switched focus.

In Indonesia, PT Toyota Motor Manufacturing Indonesia, a subsidiary of Toyota Indonesia, which manufactures and exports Toyota products, is in talks with the government to produce ventilators.

Meanwhile, Indonesia-based start-up Nusantics is preparing to make 100,000 COVID-19 test kits, in partnership with state pharmaceutical company Biofarma, the Agency for the Assessment and Application of Technology (BPPT) and the Indonesia International Institute for Life Sciences (i3L).

Read also: Indonesian medical workers threaten to stop COVID-19 treatment if protective gear not provided

A prototype will be complete within three weeks, according to the company’s investor East Ventures, which will lead crowdfunding with a target of Rp 10 billion (US$ 620,155) to produce the test kits and finance a genome sequencing project. The public can join by accessing indonesiapastibisa.com to donate money or equipment starting March 30.

“Right now, it is difficult to get tested for the coronavirus as it keeps spreading throughout the nation,” East Ventures cofounder and managing partner Willson Cuaca told the Post. “That is why we want to help the start-up achieve this goal.”

Nusantics, a technology company established in 2019, focuses on advancements in genomics and microbiome research. Microbiomes are complex ecosystems of microorganisms, such as bacteria, viruses and fungi.

The number of COVID-19 cases in Indonesia topped 1,000 on Sunday with 1,285 cases and 114 deaths, and the disease spreading to at least 30 of the country's 34 provinces. Globally, the pneumonia-like illness has infected more than 575,000 people with over 31,000 deaths. (mpr)